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Abstract
Rationale: The influence of developmental nicotine exposure on the brain represents an important health topic in light of
the popularity of nicotine replacement therapy (NRT) as a smoking cessation method during pregnancy.
Objectives: In this study, we used a model of NRT during pregnancy and breastfeeding to explore the consequences of
chronic developmental nicotine exposure on cerebral neuroplasticity in the offspring. We focused on two dynamic lifelong
phenomena in the dentate gyrus (DG) of the hippocampus that are highly sensitive to the environment: granule cell
neurogenesis and long-term potentiation (LTP).
Methods: Pregnant rats were implanted with osmotic mini-pumps delivering either nicotine or saline solutions. Plasma
nicotine and metabolite levels were measured in dams and offspring. Corticosterone levels, DG neurogenesis (cell
proliferation, survival and differentiation) and glutamatergic electrophysiological activity were measured in pups.
Results: Juvenile (P15) and adolescent (P41) offspring exposed to nicotine throughout prenatal and postnatal development
displayed no significant alteration in DG neurogenesis compared to control offspring. However, NRT-like nicotine exposure
significantly increased LTP in the DG of juvenile offspring as measured in vitro from hippocampal slices, suggesting that the
mechanisms underlying nicotine-induced LTP enhancement previously described in adult rats are already functional in
pups.
Conclusions: These results indicate that synaptic plasticity is disrupted in offspring breastfed by dams passively exposed to
nicotine in an NRT-like fashion.
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Introduction
It is estimated that 10–25% of women smoke tobacco during
pregnancy [1,2]. This addiction has well-documented adverse
effects on pregnancies, as it is associated with increased
occurrences of placenta previa, premature delivery and stillbirth,
and is the main cause of low birth weight in Western societies [3].
Furthermore, children born from mothers who smoke are more
susceptible to sudden infant death syndrome (SIDS) [4]. They
have also been reported to display cognitive deficits [5–7], and to
run a greater risk of developing psychiatric conditions including
anxiety disorders [8] and attention deficit hyperactivity disorder
(ADHD) [9,10]. These studies highlight the vulnerability of
developing brains to tobacco smoke that, in addition to the
addictive compound nicotine, contains several other neuroactive
molecules [11].
In response to the highly publicized risks associated with
smoking, combined with the difficulty of quitting, women
commonly use smoking cessation aids during pregnancy and
breastfeeding [12]. Non-prescription nicotine replacement therapy
(NRT) is the most popular of these methods [13,14], as it can help
smokers reduce withdrawal from smoking. Nicotine alone is
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e37219expected to be less harmful to the fetus than cigarette smoke [15].
Accordingly, recent studies in a Danish cohort found no evidence
that NRT increases stillbirth [16] or that it affects offspring
birthweight [17]. However, longitudinal data on NRT safety
during pregnancy and breastfeeding, and its possible influence on
cognition and behavior in offspring, have yet to be produced.
Although hundreds of studies, using a variety of nicotine
administration paradigms, have investigated the influence of
nicotine exposure during pregnancy on offspring brain develop-
ment in rodents, models of NRT during pregnancy, in which
nicotine doses yield plasma nicotine levels comparable to those
measured in humans have only recently been assessed. In
particular, using subcutaneous osmotic mini-pumps to chronically
administer high (6 mg/kg/d) or low (2 mg/kg/d) doses of nicotine
throughout pregnancy in Sprague-Dawley rats, Hussein and
collaborators showed that plasma nicotine levels measured in
dams of the high dose group (125–175 ng/ml) were much higher
than in moderate to heavy smokers (10–50 ng/ml) [18]. In
comparison, plasma nicotine levels in dams from the low dose
group were much closer (30–40 ng/ml) to these values for smokers
[18]; these values are also similar to plasma levels in abstinent
nicotine patch users (approximately 15 ng/ml) [19,20], making
this model particularly relevant to these NRT users.
Here, we have used the model examined by Hussein et al. [18]
to explore the consequences of exposure to maternal NRT-like
nicotine throughout gestation and breastfeeding on cerebral
neuroplasticity in offspring. Our investigation was focused on
two forms of neural plasticity that occur throughout life in the
dentate gyrus (DG) of the hippocampus: granule cell neurogenesis
and long-term potentiation (LTP). DG granule cell neurogenesis is
a lifelong neurodevelopmental phenomenon that has been
associated with a variety of cerebral functions such as stress
regulation [21,22] and learning and memory [23,24], and can be
persistently affected by early-life environment [25–27]. In contrast,
LTP is the synaptic mechanism thought to underlie memory
formation [28]. We report that rats chronically exposed to NRT-
like conditions during both prenatal (in utero) and postnatal
(breastfeeding) development do not display alterations in DG
neurogenesis but show significantly enhanced DG LTP compared
to saline-exposed controls.
Materials and Methods
Animals
All experiments were approved by McGill University’s Animal
Care Committee (approval ID: 5367) and followed the policies and
guidelines of the Canadian Council on Animal Care. Sprague-
Dawley rats were purchased at gestational day 2 (G2) from Charles
River (St-Constant, QC, Canada) and kept in separate cages with
water and food ad libitum. At postnatal day 2 (P2), litters were
culled to eliminate litter size-induced variability in pup growth.
Offspring weight was recorded regularly until weaning.
Nicotine and 5-bromo-29-deoxyuridine administration
At G3, dams were briefly anesthetized with isofluorane and
implanted with subcutaneous osmotic mini-pumps (Alzet; model
2006, 6 week duration) filled with sterile saline (n=9) or a solution
of nicotine bitartrate yielding 2 mg free base/kg/d nicotine (n=7).
Nicotine concentration was calculated from actual (as opposed to
projected) weight, as described previously [18]. Mini-pumps were
primed so as to deliver solutions at a constant rate (0.25 ml/h) from
subcutaneous implantation. No dams displayed abnormal recu-
peration from anesthesia or post-implantation infection. Offspring
were thus chronically exposed to nicotine in utero between
embryonic day 3 (E3) and birth, and then through breastmilk
until P21 (weaning). To assess DG cell differentiation and survival,
the thymidine analog and DNA synthesis marker 5-bromo-29-
deoxyuridine (BrdU) dissolved in 0.9% NaCl with 0.4 N NaOH
was injected in P15 pups (50 mg/kg; i.p.) either once or twice (four
hours apart). Animals were then sacrificed by cardiac perfusion
either 2 hours or 26 days (P41) later, respectively.
Plasma nicotine and nicotine metabolism
To determine plasma nicotine and cotinine (a nicotine
metabolite) levels in dams during gestation, tail-vein blood was
collected at G15 and at 7 days postpartum. Trunk blood was
collected from breastfed pups at P7 for the same purpose.
Immediately following blood collection, plasma was centrifuged at
3000 g for 10 min and frozen at 220uC until analysis by HPLC,
as described previously [29]. To compare nicotine metabolism
between developing offspring and and adults, livers from P7 and
P68 naive rats (n=5 per age) were extracted, flash frozen, and
stored at 220uC until analysis. Liver microsomal membranes were
prepared for in vitro nicotine metabolism assays as previously
described [29,30] and stored at 280uC in 1.15% KCl. The
cytosolic fractions were separated during membrane preparation
and used as a source of aldehyde oxidase. Adult liver microsome
mixtures contained 0.5 mg/ml protein, 80 ml of nicotine (0–
480 mM final concentration), 1 mM NADPH and 50 ml rat liver
cytosol in 50 mM Tris-HCl buffer (pH 7.4), and were incubated at
37uC for 20 min in a final volume of 0.5 ml. The reaction was
stopped with 100 ml 20% w/v Na2CO3, giving a final concentra-
tion of 4% w/v. After incubation 5-methylcotinine (50 mlo f
1.3 mg/ml) was added as the internal standard. For P7 rats the
assay volume was scaled down by a factor of four. The samples
were prepared and analyzed for nicotine and cotinine by HPLC as
described previously; the limits of quantification were 5 ng/ml for
nicotine and 12.5 ng/ml for cotinine.
Plasma corticosterone
To assess baseline stress hormone levels in offspring during
postnatal nicotine exposure (n=6; controls: n=7), plasma
corticosterone was measured by radioimmunoassay from trunk
blood in P15 pups using a commercial kit (MP Biomedical) with
slight modifications, and allowing for a detection threshold of
0.2 mg/dl, as described previously [31]. In brief, 5 ul of plasma in
assay buffer were heated at 65uC for 30 min to denature
corticosteroid-binding globulin and then incubated with 125I-
Corticosterone and the specific anti-corticosterone antiserum.
After overnight incubation at 4uC, the bound corticosterone was
separated from the free form by addition of a charcoal (6.25 g/L)-
dextran (0.625 g/L) solution. 15 min after addition of the charcoal
solution, tubes were centrifuged at 4uC for 30 min (3000 rpm).
The supernatant containing the bound fraction was collected into
glass tubes and counted in a gamma counter.
Cardiac perfusions
At P15 (juveniles) or P41 (adolescents), offspring were perfusion-
fixed for histological processing of their brains. Animals were
deeply anesthetized with a cocktail of ketamine (50 mg/kg),
xylazine (5 mg/kg) and acepromazine (1 mg/kg), and intracardi-
ally perfused with ice-cold phosphate-buffered saline (PBS;
50 mM) followed by 4% formaldehyde in 0.1 M phosphate
buffer. Brains were then rapidly removed, postfixed overnight at
4uC in fixative and transferred to a 30% sucrose solution until
equilibrium was reached. Brains were sliced using a cryostat into
serial 40 mm-thick coronal sections that were placed in a
cryoprotectant solution (glycerol:glycol:PBS, 3:3:4) and stored at
Early Nicotine Exposure and Hippocampal Plasticity
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described below.
Ki-67 immunocytochemistry
All immunohistochemistry incubations were performed at room
temperature unless otherwise specified. PBS washes preceded all
steps aside from addition of primary antibodies. Cell proliferation
in the DG was quantified as numbers of cells immuonoreactive
(IR) for Ki-67, a protein expressed in the nucleus of proliferating
cells. Sections were mounted on slides in PBS containing 0.2% Tx-
100 (PBS-T) and incubated in 10 mM sodium citrate buffer (pH 6,
95uC) for 15 min, then incubated in 3% H2O2 in PBS for
10 minutes and in 2% normal horse serum diluted in PBS-T for
30 min. Sections were then incubated overnight at 4uC with
monoclonal mouse anti-Ki-67 antibody (1:2000; Pharmingen) in
the same solution, followed by a 1 h incubation in biotinylated
horse anti-mouse antibody (1:200; Vector Laboratories) in this
solution, and the avidin-biotin complex procedure (ABC Kit,
Vectastain Elite; Vector Laboratories) for 30 min. Labeling was
revealed with a DAB kit (Vector Laboratories) for 5 min. Sections
were then dehydrated and coverslipped using Permount (Fisher
Scientific).
BrdU immunocytochemistry
Numbers of BrdU-IR cells at P41 (more than 3 weeks after
BrdU administration at P15) were used to asses DG cell survival.
Sections were incubated for 2 h in PBS-T, 10 min in 0.9% H2O2
in PBS, and 30 min at 37uC in 2N HCl in PBS to denature DNA.
Sections were then incubated for 30 min in PBS-T containing 2%
normal goat serum and overnight at 4uC with monoclonal rat anti-
BrdU (1:1000; Serotec) in the same solution. Sections were then
incubated for 1 h in this solution with biotinylated goat anti-rat
antibody (1:200; Vector Laboratories), followed (as above, unless
otherwise specified) by the ABC and DAB procedures (2 min),
dehydration, mounting on slides, and coverslipping.
BrdU/NeuN double-labeling immunocytochemistry
To determine the proportion of newborn cells that differenti-
ated into neurons, a subset of coronal brain sections across the
dorsal DG of BrdU-injected offspring (P41) was double-labeled for
BrdU and NeuN (a neuron-specific nuclear marker). Sections were
incubated in rat anti-BrdU (1:1000) and mouse anti-NeuN (1:200;
Chemicon) antibodies, after consecutive incubations in PBS-T
(2 h), 2 N HCl in PBS (30 min), and PBS-T containing 2% normal
goat serum (1 h). This was followed by a 1.5 h incubation in
fluorescent DyLight 594-labeled goat anti-rat (1:1500; Jackson)
and DyLight 488-labeled goat anti-mouse (1:500; Jackson)
antibodies diluted in 2% NGS in PBS-T. Sections were mounted
on glass slides and coverslipped with ProLong Gold antifade
reagent with DAPI (Invitrogen).
Cell quantifications
The section-sampling fraction for cell proliferation and survival
experiments was 1/8. For each animal, Ki-67-IR and BrdU-IR
cells were counted in the granule cell layer and adjacent
subgranular zone across the entire dorsal DG (corresponding to
Bregma -2.4 mm to -4.8 mm [32]), using an Olympus BX51 light
microscope.
BrdU/NeuN imaging was performed as described previously
[33], using a Zeiss LSM510 Meta confocal microscope with an
Axiovert 200 M stand and motorized stage (Carl Zeiss Canada),
with 488 nm and 543 nm wavelength lasers, at the Cell Imaging
and Analysis Network (CIAN) facilities at McGill University,
Montreal. For each animal, at least ten randomly-selected BrdU-
IR cells from multiple DG sections were analyzed (n=5/group),
and data expressed as the percentage of BrdU-IR cells that were
also NeuN-IR. Images were not altered except for overall
brightness and contrast. All cell quantifications were conducted
by an experimenter blinded to experimental group identity.
Basal glutamatergic transmission in the DG
To evaluate the consequences of chronic developmental NRT-
like nicotine exposure from breastmilk on basal glutamatergic
transmission in the hippocampal DG of juvenile pups, we
compared the relationship between presynaptic fiber volley
amplitude, which represents the number of presynaptic fibers
firing action potentials, and the slope of field excitatory post-
synaptic potentials (fEPSPs) in the DG. P15 offspring (saline-
exposed: n=6; nicotine-exposed: n=5) were anesthetized as
above and sacrificed to prepare 400 mm-thick coronal brain slices,
as described previously [34,35]. fEPSPs were evoked by stimulat-
ing the medial perforant pathway using a constant current pulse
and recorded from the terminal region of the medial perforant
pathway. fEPSPs were amplified using a Multiclamp 700B
amplifier (Axon), digitally stored, and analyzed off-line. Slices
displaying unstable baseline recording (610%) were discarded.
fEPSP slopes recorded from saline- and nicotine-exposed rats were
normalized by fiber volley amplitude and compared.
Long-term potentiation in the DG
In addition to granule cell neurogenesis, LTP is another major
form of functional plasticity in the DG. We therefore sought to
determine if this phenomenon is affected in juvenile rats exposed
to nicotine through breastfeeding. LTP of fEPSPs in the
hippocampal slice preparations described above were induced by
theta-burst stimulation (TBS), as a ten-burst train of four pulses
(100 Hz) with 200 ms inter-train intervals [36]. Bicuculline
methiodide (10 mM) was included in extracellular artificial
cerebrospinal fluid (aCSF) to block GABAA receptor-mediated
inhibitory post-synaptic currents (IPSCs). Changes in fEPSPs after
TBS were monitored for at least 60 min.
Statistics
Unless specified otherwise, results in each experiment were
generated from one male offspring per litter and from 5–7 litters
per group and are expressed as means 6 SEM. Electrophysiolog-
ical data (n=number of recordings) were obtained from 3–4 male
offspring from different litters. Pairwise comparisons were
performed using two-tailed t-tests with a threshold for significance
of p,0.05. Relationship between fEPSP slope and fiber volley
amplitude was examined by a regression analysis.
Results
Litter size and pup growth
Litters chronically exposed to nicotine or saline revealed no
significant difference in the average number of pups (saline:
13.261.0 vs nicotine: 12.660.8; p=0.63), or in the number of
males (saline: 6.261.0 vs nicotine: 7.361.0; p=0.44) or females
(saline: 7.060.9 vs nicotine: 5.361.0; p=0.22) per litter. Similarly,
average pup weight did not display any significant variation
between saline- and nicotine-exposed pups at any age examined
between P2 and weaning (ps=0.16–0.94) (Fig. 1). These results
are consistent with data previously obtained with the same model
by Hussein and colleagues [18].
Early Nicotine Exposure and Hippocampal Plasticity
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As illustrated in Fig. 2, plasma nicotine levels in dams measured
early in the third week of embryonic development (E15; n=7)
averaged 25.761.9 ng/ml. This value increased slightly (but non-
significantly; p=0.14) to 32.162.8 ng/ml at 7 days postpartum,
during breastfeeding. In P7 male pups, plasma nicotine levels
averaged 20.4361.1 ng/ml (n=7 litters, average of 2 pups/litter).
The levels of cotinine were relatively high in dams, at
232.1625.4 ng/ml at G15 and 163.969.6 ng/ml at 7 days
postpartum, with the postpartum value being significantly lower
(p=0.02; not illustrated) than during pregnancy. Despite easily
detectable plasma nicotine levels at P7, offspring cotinine was
undetectable in these plasma samples.
Nicotine metabolism
In order to investigate the differences in plasma levels of
cotinine observed in the P7 pups relative to the adults, the in vitro
rates of nicotine-to-cotinine metabolism were assessed. Liver
microsomes from adult rats metabolized nicotine to cotinine with
an apparent affinity constant (Km) of 169621 mM, similar to the
apparent Km in P7 rat pups of 172624 mM (n=5 different rats
for each age group, assayed twice). However, when the velocity of
this reaction was compared, the adult liver microsomes metabo-
lized nicotine with a substantially faster velocity; nicotine
concentrations near to the apparent Km (120 mM) resulted in
velocities of 0.18160.025, compared to P7 rat pup microsomes of
0.02460.004 nmol/min/mg protein (p,0.001). The apparent
Vmax was also substantially higher in adult vs P7 rats
(0.42660.015 vs 0.05760.010 nmol/min/mg protein, p,0.001).
Plasma corticosterone in breastfed pups
As shown in Fig. 3, chronic nicotine exposure did not affect
plasma corticosterone levels in P15 male pups; 1.1960.21 mg/ml
(n=6 litters; 2pups/litter) compared to 1.0860.12 mg/ml (n=7
litters; 2 pups/litter) in controls (p=0.67). These results suggest
that chronic NRT-like exposure during prenatal and postnatal
development does not alter basal stress hormone levels in pups.
Figure 1. Offspring Weight. Between postnatal day 2 (P2) and weaning (P21), the average weight of male pups exposed to maternal nicotine did
not differ significantly from that of saline-exposed controls (ps=0.16–0.94).
doi:10.1371/journal.pone.0037219.g001
Figure 2. Plasma nicotine levels in nicotine-exposed dams and their breastfed pups. Dam nicotine levels increased non-significantly
between pregnancy and post-parturition (p=0.14). E15: embryonic day 15; P7: postnatal day 7 days post-parturition.
doi:10.1371/journal.pone.0037219.g002
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Numbers of Ki-67-IR cells in the dorsal DG did not differ
significantly between saline- and nicotine-exposed offspring at
either P15 (316.94630.82 vs 301.97619.70 cells, respectively;
p=0.70) or P41 (54.8866.87 vs 43.5563.38 cells, respectively;
p=0.17) (Fig. 4). Cell survival, as assessed by the number of
BrdU-IR cells present in the DG of P41 rats that were
administered BrdU at P15 was similar in nicotine-exposed and
control groups (25.9864.26 vs 36.0866.38 cells, respectively;
p=0.22) (Fig. 5). In addition, the BrdU/NeuN confocal analysis
revealed that, nearly four weeks after BrdU administration,
roughly the same proportion of BrdU-IR cells had adopted a
neuronal phenotype (control group: 8864.9%; nicotine-exposed
group: 9264.5%; p=0.48; Fig. 6). Taken together, these data
suggest that chronic NRT-like nicotine exposure during embry-
onic development and breastfeeding does not alter DG cell
proliferation, differentiation or survival in juvenile or adolescent
offspring.
Glutamatergic synaptic transmission and LTP in the DG
The regression lines fitting fEPSPs and fiber volley amplitudes
for saline- and nicotine-exposed animals were indistinguishable
(F(2,88)=1.62, p=0.21; Fig. 7). However, LTP induced by TBS
was robustly increased in nicotine-exposed animals, suggesting
that nicotine ingested from breastmilk increases synaptic plasticity
in the immature DG (potentiation at 60 minutes after TBS:
control group: 18.265.5%; nicotine-exposed group: 40.868.7%;
p=0.037; Fig. 8).
Discussion
The model of NRT during pregnancy and breastfeeding used in
this study was chosen because it (1) mimics nicotine delivery
through transdermal patches, the most commonly employed
NRT, (2) results in maternal plasma nicotine levels similar to
those measured in humans [18], and (3) exposes offspring to
nicotine throughout prenatal and postnatal development, a period
encompassing DG development [37,38]. Postnatal nicotine
exposure in pups was assumed on the basis of previous reports
Figure 3. Plasma corticosterone in pups. Basal plasma corticoste-
rone measured in juvenile pups exposed through breastfeeding to
nicotine or saline (controls) from early embryogenesis. Corticosterone
levels did not differ between groups (p=0.67).
doi:10.1371/journal.pone.0037219.g003
Figure 4. Cell proliferation. DG proliferation assessed from Ki67-immunostained brain sections from juvenile (P15) and adolescent (P41) male
offspring exposed to saline (controls) or nicotine throughout prenatal and postnatal development. Representative micrographs of Ki67-IR cells
(arrows) in the subgranular zone or adjacent granule cell layer (gcl) in control P15 (A) and P41 (B) offspring. No significant difference in numbers of
Ki67-IR cells was found in the dorsal hippocampus of P15 (C; p=0.70) or P41 (D; p=0.17) offspring. Scale bar=25 mm.
doi:10.1371/journal.pone.0037219.g004
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upregulates brain nicotinic acetylcholine receptors (nAChRs) in
breastfed pups [40]. This maternal transfer of nicotine to breastfed
pups was confirmed here by showing that plasma nicotine levels in
juvenile offspring are comparable to those found in their mothers,
with both in the range of those measured in adult humans using
NRT [20]. Based on the results of our enzymatic analyses, the
relatively high levels of circulating nicotine we observed in
offspring were likely due to a combination of absorbance of low
levels from breast milk combined with a considerably reduced rate
of metabolism of nicotine to cotinine during the postnatal period,
as indicated by both a lack of detection of plasma cotinine in the
pups and decreased in vitro enzyme activity. These data in our rat
model are consistent with the substantially longer nicotine half-life
in human newborns (3–4 times longer than adults) [41], and
provide the first evidence that this is likely due to decreased
hepatic nicotine-to-cotinine metabolism.
In agreement with previous reports in rodents [18] and humans
[17], we found no effect of developmental exposure to NRT-like
nicotine levels on pregnancy outcome or postnatal weight. Several
nAChR subunits are strongly expressed in the hippocampus and
other brain areas as early as mid-embryogenesis [42–44]. These
subunits have been shown to form functional receptors in different
regions of the immature central nervous system [42,45], suggesting
that nicotine exposure interferes with neuronal development and
affects brain and behavior in the long-term. This hypothesis has
given rise to an extensive literature on chronic nicotine exposure
and its consequences on brain development. In particular, many
rodent studies have been published using a variety of nicotine
administration paradigms, varying with respect to route, dose,
duration and timing (e.g. [46–52]). Although these studies have
predominately shown that certain aspects of brain development
are altered by developmental nicotine exposure, inconsistent
methodology has made it difficult to fully appreciate their
relevance to humans, particularly in relation to NRT. Thus, the
aim of this study was to use and further validate in pups an NRT-
like administration paradigm to examine DG neurogenesis and
LTP, two highly neuroplastic phenomena known to be sensitive to
the environment.
Interestingly, we found that NRT-like nicotine exposure had no
significant influence on DG neurogenesis, from cell proliferation to
neuronal fate and survival. With respect to proliferation, these
findings are in line with previous studies showing that DG
proliferation is unaltered by short-term nicotine administration
[53]. The findings regarding survival were unexpected given
previous reports showing that nicotine reduces survival of
hippocampal progenitors in vitro [54], and that adult rats self-
administrating nicotine for 42 days display decreased neurogenesis
[55]. To our knowledge, the current study is the first to have
examined DG neurogenesis in immature rats exposed to nicotine.
To model the influence of NRT-like nicotine during breastfeeding,
rats were exposed to nicotine until weaning (P21). Although it
remains possible that continued nicotine exposure until sacrifice
(P42) could have altered newborn DG cell phenotype and survival,
as documented in adults by Abrous and colleagues [55], the
present data suggest that nicotinic regulation of cell proliferation
and neurogenesis in the juvenile/adolescent DG differs from that
of adults. This may be related to differential expression of a7
nAChRs, which regulate the maturation, integration and survival
Figure 5. Cell survival. Developmental nicotine exposure did not
affect survival of DG cells (p=0.22). Survival of newborn cells was
estimated from BrdU-immunostained brain sections in adolescent (P41)
offspring exposed to saline (controls) or nicotine from early embryo-
genesis until weaning and injected with BrdU at P15.
doi:10.1371/journal.pone.0037219.g005
Figure 6. Neuronal differentiation. (A) Proportion of BrdU-IR cells
differentiating into neurons in adolescent (P41) offspring exposed to
saline (controls) or nicotine from early embryogenesis until weaning
and injected with BrdU at P15 did not differ between groups (p=0.48).
(B) Orthogonal confocal image of a BrdU/NeuN-labeled DG cell (red:
BrdU; green: NeuN). Scale bar=10 mm.
doi:10.1371/journal.pone.0037219.g006
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whether DG neurogenesis in adults is influenced by early NRT-
like nicotine exposure; however, the lack of neurogenic effects seen
in the present study suggests that later stages may be unaffected as
well.
Prior to this study, NRT-like nicotine exposure during gestation
and early development had not been assessed for its consequences
on synaptic plasticity. In the absence of changes in DG
neurogenesis or fEPSPs in offspring, we found that developmental
NRT-like exposure significantly increased LTP in the DG of
juvenile pups. These results suggest that NRT-like nicotine
exposure in utero and from breastmilk enhances synaptic plasticity
in the immature DG. Nicotine administration increases expression
of cyclic AMP response element binding protein (CREB), a
transcription factor associated with plasticity, in hippocampal
neurons [57], suggesting that changes in CREB activation or
downstream transcription may underlie the LTP changes seen in
the current study. It would be interesting for future investigations
aimed at exploring the molecular mechanisms underlying the
enhanced LTP measured in this study to examine the expression
of CREB and other plasticity-related markers, such as Zif268 [58],
in the hippocampus of NRT-like exposed offspring. It is well
known that LTP in the DG is highly sensitive to exogenous stimuli
[59,60], and it has previously been shown to be enhanced ex vivo in
the hippocampi of adult rats chronically exposed to nicotine [61].
The mechanisms underlying nicotinic regulation of LTP induction
in the DG thus seem conserved throughout life. It is unknown at
present whether the increased LTP observed in juveniles persists
later in life, but it can be speculated that this significant alteration
in synaptic plasticity during a critical period of postnatal
development causes lasting changes to hippocampal circuitry.
Supporting this notion, hippocampal LTP during development is
known to drive the formation of glutamatergic synapses [62]. It is
possible that by enhancing synaptogenesis, early-life NRT
exposure would affect hippocampus-dependent cognitive func-
tions, such as learning and memory. Although increases in
hippocampal LTP are traditionally associated with increased
memory performance [63], its occurrence during development
may be functionally maladaptive [64]. In this context, it is
Figure 7. Basal synaptic transmission. Basal excitatory synaptic
transmission was not affected by nicotine exposure. Upper panel:
averaged traces of evoked field excitatory postsynaptic potential
(fEPSP) recorded from the DG of P15 rat pups. The small depolarization
ahead of fEPSP is the fiber volley, which represents the amount of
activated presynaptic fibers. Basal excitatory synaptic transmission is
therefore related to the ratio of fiber volley vs fEPSP at different
stimulating currents (see the four averaged traces). We compared this
ratio between control and nicotine-treated pups and found no
differences between these two groups (lower panel: comparing slope
of regression lines fitting fEPSPs and fiber volley amplitudes between
two groups, p=0.21).
doi:10.1371/journal.pone.0037219.g007
Figure 8. Long-term potentiation. Long-term potentiation was
enhanced by nicotine exposure. Upper panel: Scattered plots of fEPSP
against time revealed changes in fEPSP after long-term potentiation
(LTP) induction by theta-burst stimulation. Note that LTP triggered in
pups exposed to nicotine was stronger than that in control pups. Lower
panel: Average traces of fEPSP obtained at time a (before LTP induction)
and b (60 min after LTP induction) in representative recordings
obtained from saline- and nicotine-exposed pups (% potentiation at
60 minutes after TBS: p=0.037).
doi:10.1371/journal.pone.0037219.g008
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been associated with maternal smoking. Given that these effects
may be partly attributable to nicotine exposure during early
development, it has been suggested that NRT is not an ideal
therapy for pregnant smokers, as it is not sufficiently efficacious,
harmless or superior to non-pharmacological smoking cessation
therapies [65,66]. Although the NRT model used in the present
study does not suggest harmful consequences of early-life NRT
exposure on pregnancy outcome or postnatal growth, it does
reveal changes affecting connectivity in the growing brain. Future
behavioral studies using this model will need to explore whether
such changes are long-lasting, whether they affect other molecular
and physiological aspects of hippocampal plasticity, and whether
they are associated with altered cognition or affective behavior.
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